ARTICLE | Company News
Genesis, SPA merging eczema programs
November 20, 2001 8:00 AM UTC
Genesis R&D (ASX:GEN) and SR Pharma (LSE:SPA), which are both developing M. vaccae-based therapeutics for atopic dermatitis (eczema), plan to merge their programs and select 1 therapy for further deve...